Trends of Drug Synthesis in Medicinal Chemistry
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: 30 September 2025 | Viewed by 372
Special Issue Editor
2. Key Laboratory of Natural Medicines of the Changbai Mountain, Ministry of Education, Yanbian University, Yanji 133002, China
Interests: synthetic pharmaceutical chemistry; antitumor drugs; antifibrotic drugs; natural products; antibacterial agents
Special Issue Information
Dear Colleagues,
This Special Issue highlights cutting-edge advances in synthetic methodologies across anticancer, antimicrobial, antiviral, anti-inflammatory, cardiovascular, and endocrine therapeutics. With the rise of targeted drug design, green chemistry, and AI platforms redefine oncology treatment, novel small-molecule protease inhibitors combat drug-resistant pathogens, and continuous-flow systems enhance scalable production. We invite contributions exploring catalytic asymmetric synthesis, bioorthogonal chemistry, and computational modeling applications, emphasizing their roles in improving drug efficacy, sustainability, and clinical translation. This collection aims to bridge interdisciplinary insights from organic chemistry, pharmacology, and engineering, fostering discussions on next-generation synthesis paradigms for global health challenges.
Dr. Cheng-Hua Jin
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- drug synthesis
- anticancer agents
- antimicrobial resistance
- green chemistry
- AI-driven design
- targeted delivery systems
- continuous-flow technology
- structure–activity optimization
- multidisciplinary collaboration
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
